Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

THURSDAY, Sept 19, 2024 (HealthDay News) -- Exercise, whether moderate- or high-intensity, can help ease Parkinson's symptoms ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Constant tremors, difficulty standing and walking, mental disorders, and sleep disturbances are all symptoms of Parkinson's ...

Exercise, whether moderate- or high-intensity, can help ease Parkinson's symptoms, including fatigue, new research shows. As study lead author Dr. Philip Millar explained, Parkinson's patients are ...